The use of hematopoietic stem cells in autoimmune diseases

Moufida Ben Nasr, Roberto Bassi, Vera Usuelli, Alessandro Valderrama-Vasquez, Sara Tezza, Francesca D'Addio, Paolo Fiorina

Research output: Contribution to journalReview articlepeer-review


Hematopoietic stem cells (HSCs) have been shown recently to hold much promise in curing autoimmune diseases. Newly diagnosed Type 1 diabetes individuals have been successfully reverted to normoglycemia by administration of autologous HSCs in association with a nonmyeloablative regimen (antithymocyte globulin + cyclophasmide). Furthermore, recent trials reported positive results by using HSCs in treatment of systemic sclerosis, multiple sclerosis and rheumatoid arthritis as well. Early data suggested that HSCs possess immunological properties that may be harnessed to alleviate the symptoms of individuals with autoimmune disorders and possibly induce remission of autoimmune diseases. Mechanistically, HSCs may facilitate the generation of regulatory T cells, may inhibit the function of autoreactive T-cell function and may reshape the immune system.

Original languageEnglish
Pages (from-to)395-405
Number of pages11
JournalRegenerative Medicine
Issue number4
Publication statusPublished - Jun 1 2016


  • autoimmune diseases
  • hematopoietic stem cells
  • Type 1 diabetes

ASJC Scopus subject areas

  • Biomedical Engineering
  • Embryology


Dive into the research topics of 'The use of hematopoietic stem cells in autoimmune diseases'. Together they form a unique fingerprint.

Cite this